Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019
- Resource Type
- Authors
- Jason Zucker; Michael T. Yin; Elijah D LaSota; Magdalena E. Sobieszczyk; Pantelis Antoniou; Matthew Scherer; Noga Shalev
- Source
- Clinical Infectious Diseases
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
- Subject
- 0301 basic medicine
Adult
Male
Microbiology (medical)
medicine.medical_specialty
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
Sustained Virologic Response
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
030106 microbiology
Human immunodeficiency virus (HIV)
HIV Infections
medicine.disease_cause
Cohort Studies
Tertiary Care Centers
03 medical and health sciences
Immunocompromised Host
Young Adult
0302 clinical medicine
Internal medicine
Antiretroviral Therapy, Highly Active
medicine
Humans
030212 general & internal medicine
Registries
Young adult
Aged
Aged, 80 and over
business.industry
SARS-CoV-2
Brief Report
Clinical course
COVID-19
HIV
Middle Aged
Antiretroviral therapy
CD4 Lymphocyte Count
COVID-19 Drug Treatment
Hospitalization
Radiography
AcademicSubjects/MED00290
Infectious Diseases
Female
New York City
business
Cohort study
- Language
- English
- ISSN
- 1537-6591
1058-4838
We describe the characteristics of 31 people living with human immunodeficiency virus hospitalized for severe acute respiratory syndrome coronavirus 2 infection. All patients were on antiretroviral therapy and virologically suppressed at the time of admission. Clinical course and outcomes were similar to those reported in other hospitalized cohorts.